Vaccine
Serbian President Aleksandar Vucic stated on April 22 that Serbia had not participated in the testing of the vaccine of the Chinese company Sinopharm or any other manufacturer, which has been speculated on in public, but had "purchased the vaccines after their passing of all phases of testing."
Vucic stated during the video-conference with representatives of the Atlantic Council that Serbia had not "behaved geo-politically" during the procurement of vaccines and that the main goal was to save people's lives.
He recollected that vaccines of the Pfizer company were the first to arrive in Serbia. He said that, besides Pfizer, Serbia had purchased the Sinopharm, Sputnik V and AstraZeneca vaccines, and made the arrangement with Moderna for its vaccine to arrive in Serbia at the end of October.
Vucic said that "it is unavoidable for one to suffer criticism when one actually does something," and that he viewed the preservation of peace and stability in the region as the most important matter. In his words, economic success, with Serbia's growth being the second largest in Europe, was crucial for success in the procurement of vaccines, and digitalization was also important.
To get full access to all content of interest see our
Subscription offer
Or
Register for free
And read up to 5 articles each month.
Already have an account? Please Log in.